|

Tocilizumab at emerging CRS Clinical Trials

1 actively recruiting trial

Also known as: On demand

Pipeline

Phase 2: 1

Top Sponsors

  • Insel Gruppe AG, University Hospital Bern1

Indications

  • Myeloma1
  • Leukemia1
  • Lymphoma1
  • Cancer1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.